NCT07407933 2026-02-12A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsMediLink Therapeutics (Suzhou) Co., Ltd.Phase 1/2 Not yet recruiting118 enrolled